Staphylococcus aureus, or "staph," are bacteria that live on the skin and can cause infections ranging from pimples or boils to more serious infections of the internal organs. The majority of staph infections are minor and do not require treatment with antibiotics. More severe staph infections, however, are often treated with antibiotics. Methicillin-resistant staphylococcus aureus (MRSA) is a strain of staph that has become resistant to methicillin and other antibiotics.
Each licensed hospital in Washington is required to have a policy on MRSA. The policy must contain the following elements:
A hospital that has identified a hospitalized patient with a MRSA diagnosis must report the infection to the Department of Health using the state's Comprehensive Hospital Abstract Reporting System. When making the report, the hospital must use codes used by the United States Centers for Medicare and Medicaid Services, when available.
By January 1, 2023, each licensed hospital in Washington must broaden its methicillin-resistant staphylococcus aureus (MRSA) policy to include the prevention and control of the transmission of pathogens of epidemiological concern, instead of only MRSA. The elements of the policy specific to MRSA are eliminated. Instead, the policy must include:
When a hospital identifies a patient through appropriate testing who has a pathogen of epidemiological concern that is required to be reported to the United States Centers for Disease Control and Prevention's National Healthcare Safety Network, the hospital must make the report as required by the United States Centers for Medicare and Medicaid Services. The requirement for MRSA infections to be reported to the state's Comprehensive Hospital Abstract Reporting System is eliminated.
(In support) This bill reflects changing circumstances and the evolution of different pathogens. Washington's methicillin-resistant staphylococcus aureus (MRSA) specific law has not kept up with the times. It commits resources to only one, well-understood pathogen. New pathogens are constantly emerging, which is one of the key lessons that was learned from treating COVID-19 patients. Hospitals need to be prepared to address changing and accelerating threats. This bill modernizes the state's MRSA law, broadening it to require a broad risk assessment of pathogens that pose the most significant threats to patients and health care workers. The assessment will consider the likelihood of occurrence, seriousness, and measures to prevent outbreaks. This will ensure evidence-based responses to known, emergent pathogens. This bill will increase patient and worker safety by reducing outbreaks and advancing infection control practices and interventions. Trend analysis and disease surveillance from the Centers for Disease Control and Prevention and the Department of Health help to mitigate the impact of pathogens. This bill will allow hospitals to look at the entirety of risk and design sustainable interventions.
(Opposed) None.